Abstract
The bulk of evidences indicates that variations in the coding for cytokines or the regulation of their expression may play a role in acute graft-versus-host disease (aGvHD) following allogeneic hematopoietic stem cell transplantation (HSCT). It is unclear whether IL-10 promoter polymorphism is associated with the occurrence of aGvHD in allogeneic HSCT. A systematic search was performed in PubMed and Embase databases and 10 studies were identified for inclusion. Data were extracted and pooled ORs together with 95 % CIs were calculated. The pooled result indicated that −592A allele in recipient was significantly associated with reduced risk of moderate aGvHD in HSCT [OR = 0.41 (0.21, 0.79), P = 0.008, I 2 = 25 %]. The same pattern was also obtained from the −819T allele in recipient [OR = 0.38 (0.18, 0.79), P = 0.01, I 2 = 41 %]. Furthermore, we found a significant positive correlation between the −592AA homozygote and lower risk of severe aGvHD in HSCT [OR = 0.54 (0.34, 0.86), P = 0.01, I 2 = 29 %]. The similar result was gained from the −1082A allele in recipient and decreased risk of severe aGvHD [OR = 0.71 (0.52, 0.98), P = 0.04, I 2 = 19 %]. However, there was no significant association between −592A, −819T, or −1082A allele in donor and risk of aGvHD. This meta-analysis suggests that the IL-10 A allele or AA homozygote at −592, T allele at −819 and the A allele at −1082 are associated with reduced risk of aGvHD in allogeneic HSCT.
Similar content being viewed by others
References
Kaitin K. Graft-versus-host disease. N Engl J Med. 1991;325:357–8.
Beatty P, Clift R, Mickelson E, Nisperos B, Flournoy N, Martin P, Sanders J, Stewart P, Buckner C, Storb R. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985;313:765–71.
Flomenberg N, Baxter-Lowe L, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 1923;2004:104.
Petersdorf E. HLA matching in allogeneic stem cell transplantation. Curr Opin Hematol. 2004;11:386.
Perreault C, Decary F, Brochu S, Gyger M, Belanger R, Roy D. Minor histocompatibility antigens. Blood. 1990;76:1269.
Krenger W, Hill G, Ferrara J. Cytokine Cascades in Acute Graft-Versus-Host Disease 1. Transplantation. 1997;64:553.
Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott M, Oksenberg J, McNicholl J, Pociot F, Hardt C. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1:3–19.
Fiorentino D, Zlotnik A, Mosmann T, Howard M, O’garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815.
Ding L, Linsley P, Huang L, Germain R, Shevach E. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993;151:1224.
Groux H, Bigler M, De Vries J, Roncarolo M. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996;184:19.
Tseng L, Storer B, Petersdorf E, Lin M, Chien J, Grogan B, Malkki M, Chen P, Zhao L, Martin P. IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation. 2009;87:704.
Lin M, Storer B, Martin P, Tseng L, Grogan B, Chen P, Zhao L, Hansen J. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood. 2005;106:3995.
Sivula J, Turpeinen H, Volin L, Partanen J. Association of IL-10 and IL-10 R¦Â gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor. BMC immunology. 2009;10:24.
Lin M, Storer B, Martin P, Tseng L, Gooley T, Chen P, Hansen J. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. New Engl J Med. 2003;349:2201.
Bertinetto F, Dall’Omo A, Mazzola G, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet. 2006;33:375–84.
Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72:699–706.
Cavet J, Middleton P, Segall M, Noreen H, Davies S, Dickinson A. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999;94:3941.
Resende R, Correia-Silva J, Arão T, Silva T, Abreu M, Bittencourt H, Gomez R. Investigation of functional IL-10 gene polymorphism and IL-10 levels in acute graft-versus-host disease. J Clin Immunol. 2010;30:465–73.
Azarpira N, Ramzi M, Aghdaie M, Darai M, Geramizadeh B. Interleukin-10 gene polymorphism in bone marrow transplant recipients. Exp Clin Transplant. 2008;6:74.
Xiao H, Cao W, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Meng X, Zheng W. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a Chinese population. Biol Blood Marrow Transplant. 2011;17:542–9.
Przepiorka D, Weisdorf D, Martin P, Klingemann H, Beatty P, Hows J, Thomas E. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825.
Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.
Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T, Schwarer A, Szer J, Tait B, To B. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation. 2004;77:587.
Moore K, de Waal-Malefyt R, Coffman R, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol. 2001;19:683–765.
Taylor P, Lees C, Blazar B. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493.
Hoffmann P, Ermann J, Edinger M, Fathman C, Strober S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389.
Keijsers V, Verweij C, Westendorp R, Breedveld F, Huizinga T. IL-10 polymorphisms in relation to production and rheumatoid arthritis. Arthritis Rheum. 1997;40:179.
Hempel L, Körholz D, Nussbaum P, Bönig H, Burdach S, Zintl F. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant. 1997;20:365–8.
Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H, Okada M, Yamada S, Kanamaru A, Kakishita E. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. Bone Marrow Transplant. 1005;1999:24.
Holler E, Roncarolo M, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, Knabe H, Kolb H, Andreesen R, Wilmanns W. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:237.
Dickinson A, Middleton P, Rocha V, Gluckman E, Holler E. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol. 2004;127:479–90.
Helminen M, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis. 2001;184:777–81.
Temple S, Lim E, Cheong K, Almeida C, Price P, Ardlie K, Waterer G. Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics. 2003;55:629–32.
Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci. 2005;37:111–3.
Gibson AW, Edberg JC, Wu J, Westendorp RGJ, Huizinga TWJ, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001;166:3915.
Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant. 2002;2:560–7.
Acknowledgments
The National Natural Science Foundation of China (Grant No. 81072440), NSFC-Guangdong Union Grant (Grant No. U0832003) and Hubei Province Natural Science Fund project (2012FFB03708) supported this work.
Conflict of interest
The authors declare no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
12185_2013_1363_MOESM1_ESM.tif
Fig.S1. Flow chart of article selection for meta-analysis. IU = HLA-identical unrelated; IS = HLA-identical sibling; aGVHD = acute graft-versus-host disease; R = recipient; D = donor; n = number of eligible studies (TIFF 1033 kb)
About this article
Cite this article
Zhu, P., Xie, L., Yang, Y. et al. IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis. Int J Hematol 98, 102–111 (2013). https://doi.org/10.1007/s12185-013-1363-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-013-1363-3